JOSHUA MAKOWER Insider Trading $EAR Eargo, Inc.
Get free email notifications about insider trading for JOSHUA MAKOWER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JOSHUA MAKOWER. JOSHUA MAKOWER is 10% Owner in ARCA biopharma, Inc. ($ABIO) and 10% Owner in Marker Therapeutics, Inc. ($MRKR) and 10% Owner in Achaogen Inc ($AKAO) and 10% Owner in AVEO PHARMACEUTICALS INC ($AVEO) and 10% Owner in Cascadian Therapeutics, Inc. ($CASC) and 10% Owner in ARDELYX, INC. ($ARDX) and 10% Owner in GENOCEA BIOSCIENCES, INC. ($GNCA) and 10% Owner in Regulus Therapeutics Inc. ($RGLS) and 10% Owner in Trevi Therapeutics, Inc. ($TRVI) and 10% Owner in Metacrine, Inc. ($MTCR) and 10% Owner in Inozyme Pharma, Inc. ($INZY) and Director in Eargo, Inc. ($EAR) and 10% Owner in Akouos, Inc. ($AKUS) and 10% Owner in Mirum Pharmaceuticals, Inc. ($MIRM) and 10% Owner in Nkarta, Inc. ($NKTX).
JOSHUA MAKOWER in Eargo, Inc.
Industry: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
Position of JOSHUA MAKOWER: Director
Holdings: 1,858,716 shares
Latest Transaction: Oct 22 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of JOSHUA MAKOWER in Eargo, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AKAO, AKUS, ABIO, ARDX, AVEO, CASC, EAR, GNCA, INZY, MRKR, MTCR, MIRM, NKTX, RGLS, TRVI
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 22 2020 | EAR | Eargo, Inc. | MAKOWER JOSHUA | Director | Option Exercise | C | 0.00 | 1,433,459 | 0 | 0 | |
| Oct 22 2020 | EAR | Eargo, Inc. | MAKOWER JOSHUA | Director | Option Exercise | C | 0.00 | 560,789 | 0 | 0 | |
| Oct 22 2020 | EAR | Eargo, Inc. | MAKOWER JOSHUA | Director | Option Exercise | C | 0.00 | 762,959 | 0 | 0 | |
| Oct 22 2020 | EAR | Eargo, Inc. | MAKOWER JOSHUA | Director | Option Exercise | C | 0.00 | 1,274,929 | 0 | 0 | |
| Oct 22 2020 | EAR | Eargo, Inc. | MAKOWER JOSHUA | Director | Option Exercise | C | 0.00 | 546,532 | 0 | 0 | |
| Oct 22 2020 | EAR | Eargo, Inc. | MAKOWER JOSHUA | Director | Buy | P | 18.00 | 311,111 | 5,599,998 | 6,520,017 | 6.2 M to 6.5 M (+5.01 %) |
| Oct 22 2020 | EAR | Eargo, Inc. | MAKOWER JOSHUA | Director | Buy | C | 0.00 | 1,433,459 | 0 | 6,208,906 | 4.8 M to 6.2 M (+30.02 %) |
| Oct 22 2020 | EAR | Eargo, Inc. | MAKOWER JOSHUA | Director | Buy | C | 0.00 | 699,163 | 0 | 4,775,447 | 4.1 M to 4.8 M (+17.15 %) |
| Oct 22 2020 | EAR | Eargo, Inc. | MAKOWER JOSHUA | Director | Buy | C | 0.00 | 791,214 | 0 | 4,076,284 | 3.3 M to 4.1 M (+24.09 %) |
| Oct 22 2020 | EAR | Eargo, Inc. | MAKOWER JOSHUA | Director | Buy | C | 0.00 | 1,426,354 | 0 | 3,285,070 | 1.9 M to 3.3 M (+76.74 %) |
| Oct 22 2020 | EAR | Eargo, Inc. | MAKOWER JOSHUA | Director | Buy | C | 0.00 | 1,858,716 | 0 | 1,858,716 | 0 to 1.9 M |
Page: 1